ROTATEQ
POR SOL 1X2ML
| SÚKL code | 0027185 |
|---|---|
| Name of the product | ROTATEQ |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ROTATEQ |
| Supplement | POR SOL 1X2ML |
| Strenght | |
| Pharmaceutical form | Oral solution |
| Package | 1X2ML |
| Route | Oral use |
| Wrap type | Tube |
| Legal status | na lékařský předpis |
| Active substance |
LIVE ROTAVIRUS SEROTYPE G1 (ROTAVIRUS SEROTYPUS G1 VIVUM) LIVE ROTAVIRUS SEROTYPE G2 (ROTAVIRUS SEROTYPUS G2 VIVUM) LIVE ROTAVIRUS SEROTYPE G3 (ROTAVIRUS SEROTYPUS G3 VIVUM) LIVE ROTAVIRUS SEROTYPE G4 (ROTAVIRUS SEROTYPUS G4 VIVUM) LIVE ROTAVIRUS SEROTYPE P1A[8] (ROTAVIRUS SEROTYPUS P1A[8] VIVUM) |
| ATC group | J07BH02 |
| ATC group name | ROTAVIRUS, PENTAVALENTNÍ VAKCÍNA, ŽIVÝ, PŘETŘÍDĚNÝ VIRUS |
Marketing authorisation information
| Registration Number | EU/1/06/348/001 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Merck Sharp & Dohme B.V., Haarlem |
| MA Holder country | NIZOZEMSKO |
cz